graphic
graphic  
graphic
News > International
graphic
Vardenafil moves forward
graphic January 31, 2002: 5:41 p.m. ET

Bayer and GSK's anti-impotence pill accepted by Euro regulators for review.
graphic
graphic graphic
graphic
graphic
graphic       graphic
  • Viagra rival planned - Aug. 23, 2001
  • Bayer testing viagra rival - May 31, 2000
  •  
    graphic
    NEW YORK (CNN/Money) - GlaxoSmithKline PLC and Bayer AG said Thursday European regulators have agreed to review the marketing application for the companies' anti-importance medication and are expected to make a decision in the first half of 2003.

    This is another step for the joint-marketed drug Vardenafil, which is expected to compete against Pfizer Inc.'s (PFE: Research, Estimates) Viagra in treating male sexual dysfunction.

    Bayer (BAY: Research, Estimates) and GSK (GSK: Research, Estimates) said their application was accepted by the European Medicinal Evaluation Agency, and the drug is now under consideration for approval in all major markets.

    Vardenafil was submitted to U.S. regulators in December and Bayer said 85 percent of men treated with the drug experience positive results. It was submitted for approval in Japan in September.

    Eli Lilly & Co. (LLY: Research, Estimates) is also looking to get into the act with its erectile dysfunction treatment Cialis, which could be on the market at the end of this year. graphic

      RELATED STORIES

    Viagra rival planned - Aug. 23, 2001

    Bayer testing viagra rival - May 31, 2000





    graphic

    © 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
    Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
    MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
    Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
    Intraday data is at least 20-minutes delayed. All times are ET.
    Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
    Fundamental data provided by Morningstar, Inc..
    SEC Filings data provided by Edgar Online Inc..
    Earnings data provided by FactSet CallStreet, LLC.
    graphic